The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases in its newsletter, The Medical Letter on Drugs and Therapeutics. It also includes new information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings. Particular attention is paid to clinical efficacy, adverse effects, drug interactions, and cost. Our publication is intended specifically to meet the needs of busy healthcare professionals who want unbiased, reliable and timely drug information.


Publishing

The Medical Letter

Mark Abramowicz

Jean-Marie Pflomm

The Editorial Team at The Medical Letter meticulously reviews and evaluates new prescription drugs, updates on previously approved drugs, and comparative reviews of treatments for common diseases. Comprised of experienced editors and consultants, the team ensures the publication of unbiased, reliable, and timely information on clinical efficacy, adverse effects, drug interactions, and costs to inform and aid healthcare professionals in their decision-making.

Editorial Team

About

Team members